Sanofi
Why Robinhood?
You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!About SNY
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories.
SNY Key Statistics
Stock Snapshot
As of today, Sanofi(SNY) shares are valued at $50.06. The company's market cap stands at 122.7B, with a P/E ratio of 12.22 and a dividend yield of 3.3%.
As of 2025-11-25, Sanofi(SNY) stock has fluctuated between $49.25 and $50.61. The current price stands at $50.06, placing the stock +1.7% above today's low and -1.1% off the high.
The Sanofi(SNY)'s current trading volume is 1.86M, compared to an average daily volume of 2.37M.
In the last year, Sanofi(SNY) shares hit a 52-week high of $60.12 and a 52-week low of $44.62.
In the last year, Sanofi(SNY) shares hit a 52-week high of $60.12 and a 52-week low of $44.62.
SNY News
Sanofi’s (SNY) Parisian headquarters were searched on Tuesday by about 30 judicial tax officers of the National Anti-Fraud Office, two magistrates of the Nation...
Regeneron (REGN) and Sanofi (SNY) announced that the European Commission has approved Dupixent for the treatment of moderate-to-severe chronic spontaneous urtic...
(RTTNews) - Sanofi (SNY, SNYNF, SAN.PA) and Regeneron Pharmaceuticals Inc. (REGN) announced that the European Commission has approved Dupixent (dupilumab) as a...
More SNY News
Texas Attorney General Ken Paxton filed a lawsuit against pharmaceutical companies Sanofi (SNY) and Bristol-Myers Squibb (BMY) for failing to disclose that thei...
Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions AI Analyst can help you make smarter investment...